GROUP ONE TRADING, L.P. - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is and the CUSIP is 21833P903. A total of 3 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2022$2,507
-37.3%
22,700
-0.4%
0.00%
Q3 2022$4,000
-33.3%
22,8000.0%0.00%
Q2 2022$6,000
-60.0%
22,800
-18.0%
0.00%
Q1 2022$15,000
-75.8%
27,800
-72.4%
0.00%
Q4 2021$62,000
-62.0%
100,800
-37.0%
0.00%
Q3 2021$163,000
-50.8%
160,000
-11.4%
0.00%
Q2 2021$331,000
-16.4%
180,600
-10.2%
0.00%
-100.0%
Q1 2021$396,000
-2.2%
201,100
-37.9%
0.00%0.0%
Q4 2020$405,000
-45.5%
323,800
-21.5%
0.00%
-50.0%
Q3 2020$743,000
-69.6%
412,600
+41.4%
0.00%
-81.8%
Q2 2020$2,448,000
+91.8%
291,800
+19.8%
0.01%
+10.0%
Q1 2020$1,276,000
+5447.8%
243,500
+5562.8%
0.01%
Q4 2019$23,000
-20.7%
4,300
-28.3%
0.00%
Q3 2019$29,000
-66.7%
6,000
-52.4%
0.00%
-100.0%
Q2 2019$87,000
-51.4%
12,600
-51.0%
0.00%
-50.0%
Q1 2019$179,000
-22.5%
25,700
-35.1%
0.00%0.0%
Q4 2018$231,000
+7.9%
39,600
+39.4%
0.00%0.0%
Q3 2018$214,000
+529.4%
28,400
+317.6%
0.00%
Q2 2018$34,0000.0%6,800
+21.4%
0.00%
Q1 2018$34,000
-84.0%
5,600
-81.3%
0.00%
-100.0%
Q4 2017$212,000
-82.5%
29,900
-82.4%
0.00%
-90.9%
Q3 2017$1,213,000
-28.9%
169,700
-37.3%
0.01%
-38.9%
Q2 2017$1,705,000
-59.0%
270,700
-46.2%
0.02%
-62.5%
Q1 2017$4,154,000
+1595.5%
503,500
+1636.2%
0.05%
+2300.0%
Q4 2016$245,000
-64.4%
29,000
-71.4%
0.00%
-71.4%
Q3 2016$688,000101,3000.01%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q4 2020
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 323,800$405,0000.00%
SIMPLEX TRADING, LLC 821$102,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders